Created and presented by Lyes Bouzouagh, Quality Assurance Manager at Eurofins Optimed
In an ever-evolving regulatory environment, where requirements for quality, traceability, governance and data integrity continue to strengthen, preparation for a regulatory inspection can no longer be considered a one-off, downstream exercise. It must now be embedded from the very outset — at the design stage of the study, processes, systems and organisational structure.
This one-hour webinar will provide a methodological, operational and strategic perspective on inspection readiness, in light of the principles set out in ICH E6(R3). It will highlight current health authority expectations, as well as practical levers enabling sponsors, CROs and investigative sites to build a robust, risk-proportionate and inspection-defensible framework.
Registrations are now closed.
If you missed the live session, you can watch the replay (in French with English subtitles)
How can organisations demonstrate effective risk management? Why should inspection readiness be embedded from the very start of a study? What are the key considerations when it comes to the TMF, CAPAs and quality documentation?
This article brings together the main insights and recommendations shared by Lyes Bouzouagh, Quality Assurance Manager at Eurofins Optimed, helping clinical research professionals strengthen regulatory compliance and maintain a state of inspection readiness.